Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 443 | -113 | 323 | 903 | -163 |
| Accounts receivable | -581 | -878 | 740 | 324 | -483 |
| Accounts payable and accrued liabilities | 355 | 781 | -186 | -103 | 189 |
| Other Working Capital | -3,998 | 3,690 | 332 | 538 | -232 |
| Other Operating Activity | -3,611 | -2,342 | -3,364 | -2,439 | -2,351 |
| Operating Cash Flow | $-7,392 | $1,138 | $-2,154 | $-777 | $-3,040 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71 | -205 | -113 | 3 | -33 |
| Net Acquisitions | 0 | -1,072 | 1,900 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -506 | 0 |
| Investing Cash Flow | $-71 | $-1,278 | $1,787 | $-504 | $-33 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -319 | N/A | N/A | N/A | N/A |
| Debt Repayment | -29 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 7,604 | 0 | 0 | N/A | N/A |
| Common Stock Repurchased | 0 | 0 | 0 | 157 | -488 |
| Other Financing Activity | 120 | 219 | 401 | -682 | -67 |
| Financing Cash Flow | $7,376 | $219 | $401 | $-525 | $-555 |
| Beginning Cash Position | 368 | 288 | 254 | 2,060 | 5,687 |
| End Cash Position | 281 | 368 | 288 | 254 | 2,060 |
| Net Cash Flow | $-87 | $80 | $34 | $-1,805 | $-3,628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,392 | 1,138 | -2,154 | -777 | -3,040 |
| Capital Expenditure | -71 | -205 | -113 | N/A | -33 |
| Free Cash Flow | -7,463 | 933 | -2,267 | -777 | -3,072 |